FDA: More Female Libido Studies!

The company behind an experimental drug for boosting sexual desire in women faces another new hurdle, as the FDA is now asking for more data on how the drug interacts with other medications, as well as on driving ability. In nearly 10 percent of company trials, women reported sleepiness when using the drug, dubbed flibanserin. If Sprout Pharmaceuticals’ drug is approved, it would be the first such drug for women, and a potential blockbuster that drug companies have been trying to achieve since the success of Viagra for men.